• Bionote postponed its extraordinary shareholders' meeting to Dec. 10, 2026, from Nov. 26, 2026; the start time remains 9 a.m.
• Shareholders will vote on appointing three independent directors to serve on the audit committee.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bionote Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261110800406), on November 10, 2026, and is solely responsible for the information contained therein.